Regenerative biotechnology
CTM Procaine
Mesenchymal stem cells pre-stimulated with procaine for regenerative and immunomodulatory support.
Injectable solution of mesenchymal stem cells pre-stimulated with procaine that enhances tissue regeneration, modulates the immune response, and reduces chronic inflammatory processes.
Composition
Mesenchymal stem cells pre-stimulated with procaine.
Pharmaceutical form
Injectable solution.
Presentation
Monovette with 4 ml.
Therapeutic Properties
Tissue regeneration, immunomodulation, and reduction of inflammation through functional enhancement of mesenchymal stem cells pre-stimulated with procaine.
- Enhancement of tissue regeneration.
- Modulation of the immune response.
- Reduction of chronic inflammation.
- Improvement of cellular migration.
- Inhibition of cellular apoptosis.
- Delay of cellular aging.
- Inhibition of cellular apoptosis.
- Support in autoimmune pathologies.
Mechanism of action & Clinical data
Procaine pre-stimulates CTMs, improving migration, viability, release of anti-inflammatory cytokines, and regenerative factors.
Indications
Adjuvant in chronic-degenerative diseases, autoimmune diseases, and chronic inflammatory processes.
Administration
Slow intravenous administration diluted in 0.9% saline solution, not as a bolus.
Contraindications
Sensitivity to formula components and diagnosis of neoplasia.
Storage
Refrigerate between 2 and 8 ℃, protected from light, do not freeze.
